These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 21664647)

  • 1. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
    Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
    Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
    Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
    Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
    Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.
    Zlobec I; Lugli A; Baker K; Roth S; Minoo P; Hayashi S; Terracciano L; Jass JR
    J Pathol; 2007 Jul; 212(3):260-8. PubMed ID: 17516584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.
    Zlobec I; Terracciano L; Tornillo L; Günthert U; Vuong T; Jass JR; Lugli A
    Gut; 2008 Oct; 57(10):1413-9. PubMed ID: 18436576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.
    Koelzer VH; Baker K; Kassahn D; Baumhoer D; Zlobec I
    J Clin Pathol; 2012 Nov; 65(11):996-1002. PubMed ID: 22859396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
    Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
    Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
    Karamitopoulou E; Lugli A; Panayiotides I; Karakitsos P; Peros G; Rallis G; Patsouris ES; Terracciano L; Zlobec I
    Histopathology; 2010 Aug; 57(2):233-43. PubMed ID: 20716165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting.
    Betge J; Pollheimer MJ; Lindtner RA; Kornprat P; Schlemmer A; Rehak P; Vieth M; Hoefler G; Langner C
    Cancer; 2012 Feb; 118(3):628-38. PubMed ID: 21751188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour budding at invasive margins and outcome in colorectal cancer.
    Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
    Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
    Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
    Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.
    Torres C; Turner JR; Wang HH; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
    Cancer; 1999 Feb; 85(3):520-8. PubMed ID: 10091725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
    Tornillo L; Lugli A; Zlobec I; Willi N; Glatz K; Lehmann F; Spichtin HP; Maurer R; Stoios D; Sauter G; Terracciano L
    Am J Clin Pathol; 2007 Jan; 127(1):114-23. PubMed ID: 17145638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
    Karamitopoulou E; Zlobec I; Born D; Kondi-Pafiti A; Lykoudis P; Mellou A; Gennatas K; Gloor B; Lugli A
    Eur J Cancer; 2013 Mar; 49(5):1032-9. PubMed ID: 23177090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes.
    Zlobec I; Terracciano LM; Lugli A
    Clin Cancer Res; 2008 Jun; 14(12):3792-7. PubMed ID: 18559598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
    Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
    Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.